Concepedia

Publication | Open Access

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

2K

Citations

23

References

2002

Year

Abstract

Imatinib induced high rates of cytogenetic and hematologic responses in patients with chronic-phase CML in whom previous interferon therapy had failed.

References

YearCitations

Page 1